Advances and challenges in gene therapies (part 2)

Wednesday, September 14, 2022

PLENARY

• 14-PM-PLENARY • 2:30 PM > 4:00 PM • Advances and challenges in gene therapies (part 2) • Apollon Auditorium

2:30 PM • S12L1 • X-linked myotubular myopathy and liver dysfunction > A. Ana BUJ-BELLO 3:00 PM • S12L2 • Modelling and editing Duchenne Muscular Dystrophy > W-H. Wolfram-Hubertus ZIMMERMANN 3:30 PM • S12L3 • Application of CRISPR/Cas9 strategy for gene therapy of Myotonic Dystrophy type 1 > G. Germana FALCONE